Erdheim-Chester disease (ECD) is a rare disease which occurs in adults. It is identified by excessive accumulation and production of histiocytes (white blood cells) within organs and tissues. The Histocytes are basically macrophages which react to injuries and infections.
This report contains market size and forecasts of Erdheim Chester Disease Treatment in Global, including the following market information:
Global Erdheim Chester Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erdheim Chester Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erdheim Chester Disease Treatment include Bausch Health, Cadila Healthcare, SANIS, Aphena Pharma Solutions, Roche, Cardinal Health, Pfizer and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erdheim Chester Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erdheim Chester Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erdheim Chester Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Immunotherapy
Chemotherapy
Global Erdheim Chester Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erdheim Chester Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Erdheim Chester Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erdheim Chester Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erdheim Chester Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erdheim Chester Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Cadila Healthcare
SANIS
Aphena Pharma Solutions
Roche
Cardinal Health
Pfizer
Novartis